Inventor
Carrie K. Jones
Inventor
Nashville, TN, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes25%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,342,782Positive allosteric modulators of the muscarinic acetylcholine receptor M420199,844,542Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR520179,255,103'Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators'20169,090,632'Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors'20159,085,562'6-alkyl-N-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same'20158,865,725'Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors'20148,853,392'Benzamide mGluR5 positive allosteric modulators and methods of making and using same'20148,853,237'Naphthyridinone analogs as mGluR5 positive allosteric modulators'20148,796,295'Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same'20148,703,946'Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors'20148,598,345'Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same'20138,592,422'Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors'20138,569,308'Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same'20138,501,757'Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same'20138,497,289'3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same'20138,436,019'Sulfonyl-piperidin-4-yl methylamine amide analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders'20138,431,700'Alkylsulfonyl-2,3-dihydrospiro[indene-1,4′-piperidine] analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders'20138,207,155'Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders'20128,034,806'Bicyclic mGluR5 positive allosteric modulators and methods of making and using same'20117,531,541'Partial mGluR5 antagonists for treatment of anxiety and CNS disorders'20096,245,802'Method for treating pain'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001Based in Indianapolis, IN, US· patent location history
2009–2019Patents assigned to UNIV VANDERBILT (20)· patent assignee history
2009–2019Based in Nashville, TN, US· patent location history
2012–2015Patents assigned to CONN P JEFFREY (15)· patent assignee history
2012–2015Patents assigned to JONES CARRIE K (15)· patent assignee history
2012–2015Patents assigned to LINDSLEY CRAIG W (15)· patent assignee history
2013–2015Patents assigned to RODRIGUEZ ALICE L (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV VANDERBILT | 20 | 2009–2019 |
| CONN P JEFFREY | 15 | 2012–2015 |
| JONES CARRIE Kself | 15 | 2012–2015 |
| LINDSLEY CRAIG W | 15 | 2012–2015 |
| RODRIGUEZ ALICE L | 6 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nashville, TN, US | 20 | 2009–2019 |
| Indianapolis, IN, US | 1 | 2001 |